Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Optinose Inc (NQ: OPTN ) 0.7100 +0.0400 (+5.97%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Optinose Inc < Previous 1 2 3 4 5 Next > Optinose Announces Reporting Date for Third Quarter 2024 Financial Results November 05, 2024 Conference Call and Webcast to be held November 12, 2024, at 8:00 a.m. Eastern Time From Optinose, Inc. Via GlobeNewswire Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 16, 2024 From Optinose, Inc. Via GlobeNewswire Optinose Appoints Terry Kohler as Chief Financial Officer October 07, 2024 From Optinose, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session September 27, 2024 Via Benzinga New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus Surgery September 05, 2024 From Optinose, Inc. Via GlobeNewswire Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference August 26, 2024 From Optinose, Inc. Via GlobeNewswire OPTN Stock Earnings: OptiNose Beats EPS, Misses Revenue for Q2 2024 August 08, 2024 OPTN stock results show that OptiNose beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. Via InvestorPlace Optinose Reports Second Quarter 2024 Financial Results and Recent Operational Highlights August 08, 2024 From Optinose, Inc. Via GlobeNewswire Optinose Announces Reporting Date for Second Quarter 2024 Financial Results August 02, 2024 Conference Call and Webcast to be held August 8, 2024, at 8:00 a.m. Eastern Time From Optinose, Inc. Via GlobeNewswire 7 Little-Known Penny Stocks That Can Turn $10K Into $1 Million July 02, 2024 Check out these explosive penny stocks with massive growth potential that could turn a modest $10,000 investment into a life-changing $1 million. Via InvestorPlace Expanded Access to XHANCE with Addition to National Commercial Formularies June 27, 2024 From Optinose, Inc. Via GlobeNewswire Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ May 17, 2024 From Optinose, Inc. Via GlobeNewswire Why Doximity Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket May 17, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session May 16, 2024 Via Benzinga OPTN Stock Earnings: OptiNose Misses EPS, Beats Revenue for Q1 2024 May 14, 2024 OPTN stock results show that OptiNose missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights May 14, 2024 From Optinose, Inc. Via GlobeNewswire Optinose Announces Reporting Date for First Quarter 2024 Financial Results May 10, 2024 Conference Call and Webcast to be held May 14, 2024, at 10:00 a.m. Eastern Time From Optinose, Inc. Via GlobeNewswire Optinose Announces $55 Million Registered Direct Offering May 09, 2024 From Optinose, Inc. Via GlobeNewswire Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 25, 2024 Via Benzinga Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts April 25, 2024 Bristol-Myers Squibb layoffs will see the company reduce its headcount by 6% as part of an effort to reduce expenses in 2024. Via InvestorPlace Topics Workforce Exposures Layoff Why Are Stocks Down Today? April 25, 2024 Stocks are down today and investors wondering why have come to the right place as we have all the news on the market drop on Thursday. Via InvestorPlace Why Is OptiNose (OPTN) Stock Up 12% Today? April 25, 2024 OptiNose stock is taking off on Thursday alongside an update on XHANCE that brings heavy trading to OPTN shares this morning. Via InvestorPlace Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million April 25, 2024 Conference Call and Webcast to be held April 25, 2024, at 10:00 a.m. Eastern Time From Optinose, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session April 22, 2024 Via Benzinga Optinose to Present at the Needham Virtual Healthcare Conference April 04, 2024 From Optinose, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session March 15, 2024 Via Benzinga XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps March 15, 2024 From Optinose, Inc. Via GlobeNewswire OPTN Stock Earnings: OptiNose Meets EPS, Beats Revenue for Q4 2023 March 07, 2024 OPTN stock results show that OptiNose met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. Via InvestorPlace Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights March 07, 2024 From Optinose, Inc. Via GlobeNewswire Earnings Scheduled For March 7, 2024 March 07, 2024 Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
